Bayer sees glyphosate settlement only if financially reasonable

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/10/2026

1. SPCX
2. HUM
3. ALHC
4. PEP
5. T
6. CVS
7. UNH
8. SPY
9. SBUX
10. AXP

Go back to Bayer sees glyphosate settlement only if financially reasonable

FDA Approves Bayer's (BAYRY) Nubeqa for Prostate Cancer

July 31, 2019 8:39 AM EDT

Bayer AG (OTC: BAYRY) announced the FDA approved Nubeqa®(darolutamide), an androgen receptor inhibitor (ARi), for the treatment of patients with non-metastatic castration-resistant prostate cancer (nmCRPC).1 The FDA approval is based on the Phase III ARAMIS trial evaluating Nubeqa plus androgen deprivation therapy (ADT), which... More

Bayer AG (BAYN:GR) (BAYRY) PT Lowered to EUR69 at JPMorgan

July 31, 2019 2:24 AM EDT

JPMorgan analyst Richard Vosser lowered the price target on Bayer AG (BAYN:GR) (OTC: BAYRY) to EUR69.00 (from EUR70.00) while maintaining a Neutral rating.

... More